The medical device company unveils a new strategic plan and sets ambitious financial targets for 2028, including plans to accelerate revenue growth and improve profitability.
The healthcare company has disclosed changes to the shareholdings of its directors and other persons discharging managerial responsibilities.
The healthcare company has announced a change in shareholding, with BlackRock, Inc. increasing its stake to 7.17%.
The healthcare company has announced the vesting of restricted shares for its Chief Executive Officer.
The healthcare company has reported a change in major shareholding.
The healthcare company has disclosed changes in shareholdings by its directors and other persons discharging managerial responsibilities.
The healthcare company has disclosed a transaction involving the purchase of American Depositary Shares by a person closely associated with an independent non-executive director.
The healthcare company has announced a change in shareholding by a senior executive.
The medical technology company has appointed Thérèse Esperdy as an independent Non-Executive Director and Senior Independent Director designate, effective from 1 December 2025.
The medical device maker reported 5.0% underlying revenue growth in Q3 and raised its full-year free cash flow guidance, signaling a positive outlook.